3.75
+0.09(+2.46%)
Currency In USD
| Previous Close | 3.66 |
| Open | 3.74 |
| Day High | 3.79 |
| Day Low | 3.68 |
| 52-Week High | 5.44 |
| 52-Week Low | 2.36 |
| Volume | 59,210 |
| Average Volume | 33,717 |
| Market Cap | 4.05M |
| PE | -0.49 |
| EPS | -7.61 |
| Moving Average 50 Days | 3.59 |
| Moving Average 200 Days | 3.43 |
| Change | 0.09 |
If you invested $1000 in Heart Test Laboratories, Inc. (HSCS) since IPO date, it would be worth $15.5 as of June 30, 2025 at a share price of $3.75. Whereas If you bought $1000 worth of Heart Test Laboratories, Inc. (HSCS) shares 2 years ago, it would be worth $41.44 as of June 30, 2025 at a share price of $3.75.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
GlobeNewswire Inc.
Jun 04, 2025 1:00 PM GMT
Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed for Seamless Integration with Hospital EHR SystemsSouthlake, TX, June 04, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
GlobeNewswire Inc.
Jun 03, 2025 1:00 PM GMT
Patent covers estimation of measures of heart function using an ECG, which are critical in the diagnosis and early detection of heart diseaseSouthlake, TX, June 03, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences”
HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
GlobeNewswire Inc.
May 20, 2025 1:00 PM GMT
Southlake, TX, May 20, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier